• Phentermine
• Belviq/Belviq XR
• Contrave
• Qysmia
• Saxenda
• Xenical
• Benzphetamine
• Diethylpropion
• Phendimetrazine

Who is a candidate for anti-obesity drugs?

Person has a BMI (body mass index) greater than or equal to 30.

The person has a BMI greater than or equal to 27 but less than 30 and two or more of the following risk factors:

• Coronary heart disease
• Dyslipidemia
• Hypertension
• Sleep apnea
• Type II diabetes mellitus

Most anti-obesity drugs are approved for weight loss in adults who meet the following criteria:

• The patient is 18 years of age or older.
• The patient is not pregnant or nursing.
• The patient does not have a history of an eating disorder (e.g., anorexia, bulimia).
• The patient has not had bariatric surgery.

The person has participated in a weight loss treatment plan (e.g., nutritional counseling, an exercise regimen, a calorie-restricted diet) in the past six months and will continue to follow the treatment plan while taking an anti-obesity drug

0–9

• 5-HT2C receptor agonist

A

• AdipoRon
• Azalanstat

B

• Beloranib
• Benfluorex
• Benzphetamine
• Bupropion
• Bupropion/naltrexone
• Bupropion/zonisamide

C

• Cetilistat

D

• Dexfenfluramine
• 2,4-Dinitrophenol
• Dirlotapide

E

• Etiocholanedione

F

• Fenbutrazate
• Fluasterone

L

• Liraglutide
• Lorcaserin

M

• Mitratapide

O

• Obocell
• Oleoyl-estrone
• Orlistat

P

• Phendimetrazine
• Phentermine/topiramate
• Prohibitin-targeting peptide 1

S

• Setmelanotide

T

• Tesofensine

V

• Vabicaserin